Dr. 정영화
Dr. Jung Yeong Hwa
학력
1990 .03 ~ 1993 .02고려대학교 의학 박사
1982 .03 ~ 1984 .02서울대학교 의학 석사
1975 .03 ~ 1981 .02서울대학교 의학 학사
경력
2000 .03 ~ 현재울산의대 서울아산병원 소화기내과 교수
1995 .10 ~ 2000 .02울산의대 서울아산병원 소화기내과 부교수
1991 .03 ~ 1995 .09울산의대 서울아산병원 소화기내과 전임강사
1989 .03 ~ 1991 .02울산의대 서울아산병원 소화기내과 전임강사
1988 .05 ~ 1989 .02서울대학병원 소화기내과 전임의
1982 .03 ~ 1985 .02서울대학병원 내과 전공의
1981 .04 ~ 1982 .02서울대학병원 인턴
논문
A Case of Surgical Removal of a Migrated Coil after Embolization of Jejunal Variceal Bleeding
Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion.
Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.
Clinical characteristics and potential etiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic areas.
Comprehensive outcomes of on- and off-antiviral prophylaxis in hepatitis B patients undergoing cancer chemotherapy: A competing risks analysis.
A Patient-Based Nomogram for Predicting Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma.
Comparison of Chemoembolization with and without Radiation Therapy and Sorafenib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Propensity Score Analysis
Comparison of chemoembolization with and without radiation therapy and sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis.
Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma
Intimate association of visceral obesity with non-alcoholic fatty liver disease in healthy Asians: A case-control study.
Nomograms for Predicting Outcomes after Chemoembolization in Patients with Nonmetastatic Hepatocellular Carcinoma.
Response to Letter Regarding Article, "Prevalence and Prediction of Coronary Artery Disease in Patients With Liver Cirrhosis: A Registry-Based Matched Case-Control Study".
Clinical aspects of tumor necrosis factor-α signaling in hepatocellular carcinoma.
Optimal methods for measuring eligibility for liver transplant in hepatocellular carcinoma patients undergoing transarterial chemoembolization
Prevalence and prediction of coronary artery disease in patients with liver cirrhosis: a registry-based matched case-control study.
Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinoma
The first case report of composite bone marrow involvement by simultaneously developed peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma.
Tumor Necrosis Factor-Alpha Gene Polymorphism Associated With Development of Hepatitis B Virus-associated Hepatocellular Carcinoma.
Clinical Implications of Arrest-Defective Protein 1 Expression in Hepatocellular Carcinoma: A Novel Predictor of Microvascular Invasion
Clinical course of chronic hepatitis B patients who were off-treated after lamivudine treatment: analysis of 138 consecutive patients.
Effect of Response to Interferon-alpha Therapy on the Occurrence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
Exercise and diet modification in non-obese non-alcoholic fatty liver disease: Analysis of biopsies of living liver donors
Factors Predisposing Metastatic Tumor Antigen 1 Overexpression in Hepatitis B Virus Associated Hepatocellular Carcinoma
Genetic predisposition of hand-foot skin reaction after sorafenib therapy in patients with hepatocellular carcinoma.
Half-Life of Serum Alpha-Fetoprotein: An Early Prognostic Index of Recurrence and Survival After Hepatic Resection for Hepatocellular Carcinoma.
High HBV-DNA Titer in Surrounding Liver Rather Than in Hepatocellular Carcinoma Tissue Predisposes to Recurrence After Curative Surgical Resection
Interim analysis of start: Study in asia of the combination of TACE (Transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trial.
Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis
Polymorphisms of DNA repair genes in Korean hepatocellular carcinoma patients with chronic hepatitis B: Possible implications on survival
Radiotherapy Plus Transarterial Chemoembolization for Hepatocellular Carcinoma Invading the Portal Vein: Long-Term Patient Outcomes
Relationship of HLA-DRB1 Alleles With Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients
Roads towards a new tailored therapy for hepatocellular carcinoma: diagnostic, therapeutic and prognostic implications of microRNAs
Single nucleotide polymorphisms associated with metastatic tumour antigen 1 overexpression in patients with hepatocellular carcinoma
rtL180M mutation of hepatitis B virus is closely associated with frequent virological resistance to adefovir dipivoxil therapy
Transforming Growth Factor Beta 1 Overexpression Is Closely Related to Invasiveness of Hepatocellular Carcinoma
Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant center.
Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: does transarterial chemoembolization improve survival in these patients?
Could HBx Protein Expression Affect Signal Pathway Inhibition by Gefitinib or Selumetinib, a MEK Inhibitor, in Hepatocellular Carcinoma Cell Lines?
HLA-DRB1 * 010101 Allele Is Closely Associated with Poor Virological Response to Lamivudine Therapy in Patients with Chronic Hepatitis B.
High prevalence of hepatitis Band hepatitis C virus infection in Korean patients with hematopoietic malignancies.
Histologic Characteristics Predisposing to Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B.
Noninvasive diagnostic criteria for hepatocellular carcinoma in hepatic masses >2 cm in hepatitis B virus-endemic area.
Posttransplantation prophylaxis with primary high-dose hepatitis B immunoglobulin monotherapy and complementary preemptive antiviral add-on.
Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis.
Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology.
Genetic Variations at Loci Involved in the Immune Response Are Risk Factors for Hepatocellular Carcinoma.
High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies.
How to overcome multidrug resistance in chemotherapy for advanced hepatocellular carcinoma.
Impacts of Vaccination on Hepatitis B Viral Infections in Korea over a 25-Year Period.
Lamivudine plus adefovir or entecavir for patients with chronic hepatitis b resistant to lamivudine and adefovir.
Sigmoid colon metastasis from hepatocellular carcinoma.
중증 간질환을 동반한 적혈구조혈성 포르피린증 환자에서의 cholestyramine 치료: 사례보고
C형간염바이러스 유전자형 1b에 감염된 한국인 환자에서 인터페론 감수성 결정 영역의 유전자 돌연변이 양상
Antifibrogenic effects of tamoxifen in a rat model of periportal hepatic fibrosis.
Clinical Significance of Serum Osteopontin in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
Complete Necrosis After Transarterial Chemoembolization Could Predict Prolonged Survival in Patients with Recurrent Intrahepatic Hepatocellular Carcinoma After Curative Resection.
Hepatitis B virus with the rtL80V/I mutation is associated with a poor response to adefovir dipivoxil therapy.
Surgical Treatments and Prognoses of Patients with Combined Hepatocellular Carcinoma and Cholangiocarcinoma
Liver International News: Reports from South Korea
Metastatic tumor antigen 1 is closely associated with frequent postoperative recurrence and poor survival in patients with hepatocellular carcinoma.
Preoperative portal vein embolization and surgical resection in patients with hepatocellular carcinoma and small future liver remnant volume: comparison with transarterial chemoembolization.
특발성 비신단락을 동반한 간경변증 환자의 간성 척수병증 2예
Biochemical Rather than Virologic Response to Interferon Therapy may be More Closely Associated with Decrease of Hepatocellular Carcinoma Incidence in Patients with Chronic Hepatitis B
Clevudine therapy for 24 weeks further reduced serum hepatitis B virus DNA levels and increased ALT normalization rates without emergence of viral breakthrough than 12 weeks of clevudine therapy.
Clinical Outcome after Living Donor Liver Transplantation in Patients with Hepatitis C Virus-associated Cirrhosis
Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors.
Increased risk of adeforvir resistance in patients with lamivudine-resistant chronic heapatitis B after 48 weeks of adfovir dipivoxil monotherapy
Molecular Mechanisms of Hepatitis B Virus-associated Hepatocellular Carcinoma
Molecular pathogenesis of hepatitis B virus-associated hepatocellular carcinoma
Preoperative portal vein embolization and surgical resection in patients with hepatocellular carcinoma and small future liver remnant volume: comparison with transarterial chemoembolization.
Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center.
Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B.
진행된 간세포암에서의 간문맥 혈전증에 대한 방사선치료 효과
Association of specific amino acid sequence of HLA-DR with autoimmune hepatitis
Chronic hepatitis B in hepatocarcinogenesis.
Clinical Features And Outcomes of Hepatic Failure Assoiciated with Epstein-Barr Virus lnfection
Clinical Features And Outcomes of Severe Epstein-Barr Virus Hepatitis Presented with Jaundice
Clinical Features of Fulminant Hepatic Failure in a Tertiary Hospital with a Liver Transplant Center in Korea
Increased risk of adefovir resistance in patients with Iamivudine-resistant chronic hepatitis B after 48 weeks of adfovir dipivoxil monotherapy
Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy.
Metachronous colorectal cancer
Nine Cases of Sporadic Acute Hepatitis E in Korea
Safety and Efficacy of Three-Dimensional Conformal Radiotherapy for Portal Vein Tumor Thrombus by Hepatocellular Carcinoma
간세포암의 문맥 침범에 대한 방사선치료의 효과와 안전성
A형 간염 바이러스에 의한 전격성 간부전 5예의 임상 경과
간세포암의 하대정맥 침범에 대한 방사선치료의 효과
Adefovir dipivoxil alone or in combination with ongoning lamivudine in patients with decompensated liver disease and lamivudine-resistant hepatitis B virus
Precore stop codon mutation of hepatitis B virus is associated with low breakthrough rate following long-term lamivudine therapy.
The effect of preoperative transarterial chemoembolization on the patient's outcome in resectable hepatocellular carcinoma.
Usefulness of reagent strips for the diagnosis of spontaneous bacterial peritonitis.
한국 성인 자가 면역성 간염 환자들에서 감수성 조직적합항원(HLA) 분석
최근 3년간 급성 바이러스성 간염의 원인 분석
전격성 간부전의 원인, 임상양상, 사망예견인자
절제가능한 간세포암에서 수술 전 경동맥화학색전술의 효과
Characteristic clinical features of hepatocellular carcinoma associated with Budd-Chiari syndrome: evidence of different carcinogenic process from hepatitis B virus-associated hepatocellular carcinoma.
Combination of alpha-interferon with lamivudine reduces viral breakthrough during long-term therapy.
Differential Expression of Promyelocytic Leukemia Protein in Autoimmune Liver Diseases
Radioresponse of Hepatocellular Carcinoma-Treatment of Lymph Node Metastasis
Role of additional angiography and chemoembolization in patients with hepatocellular carcinoma who achieved complete necrosis following transarterial chemoembolization.
Which patients with chronic hepatitis B are more likely to relapse after interferon alpha-induced hepatitis B e antigen loss in Korea?
Clinical manifestations of autoimmune liver diseases in Korea
Expression of DNA methyltransferases in multistep hepatocarcinogenesis
Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
Long-term additional lamivudine therapy enhances durability of lamivudine-induced HBeAg loss: a prospective study
Quantitative polymerase chain reaction assay for serum hepatitis B virus DNA as a predictive factor for post-treatment relapse after lamivudine induced hepatitis B e antigen loss or seroconversion.
Recent increase in antibiotic-resistant microorganisms in patients with spontaneous bacterial peritonitis adversely affects the clinical outcome in Korea.
p16 Hypermethylation in the early stage of hepatitis B virus-associated hepatocarcinogenesis
타목시펜이 간세포암 세포주의 성장과 Transforming Growith Factor-b 1의 발현에 미치는 영향
Clinical and Microbiological Characteristics of Spontaneous Bacterial Peritonitis (SBP) in A Recent Five Year Period
Four cases of hepatitis B virus-related fibrosing cholestatic hepatitis treated with lamivudine.
Lens culinaris agglutinin-reactive alpha-fetoprotein as a prognostic marker in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization.
Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization
Therapeutic Efficacy of Lamivudine in Patients With Hepatitis B Virus-Related Decompensated Cirrhosis in Korea
Therapeutic Efficacy of Transjugular Intrahepatic Portosystemic Shunt on Bleeding Gastric Varices
Transforming growth factor-beta1 as a useful serologic marker of small hepatocellular carcinoma.
Validation of International Autoimmune Hepatitis Group Scoring System for Diagnosis of Type 1 Autoimmune Hepatitis in Korea
간경변 환자에서 혈청 lipoprotein(a)와 저밀도 지단백 콜레스테롤 및 apolipoprotein(a)의 상관관계
A Case of Granulomatous Hepatitis Associated with Common Variable Immunodeficiency
Association between insulin-like growth factor-2 and metastases after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma: a prospective study.
Close correlation of p53 mutation to microvascular invasion in hepatocellular carcinoma.
Efficacy and safety of lamivudine therapy in patients with liver cirrhosis associated with chronic hepatitis B
Efficacy of Repeated Arterial Infusion of Cisplatin and 5-Fluorouracil via a Percutaneously Implantable Port System in Advanced Hepatocellular Carcinoma
Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma
Isocitrate dehydrogenase as a marker of centrilobular hepatic necrosis in the experimental model of rats.
Plasma isocitrate dehydrogenase as a marker of centrilobular hepatic necrosis in patients with hyperthyroidism.
진행성 간세포암종에서 Percutaneously Implantable Port System을 통한 간동맥 내 Cislatin과 5-Fluorouracil 복합화학요법의 효과
간세포암종과 주변 간조직에서 tumor necrosis factor-related apoptosis-inducing ligand(TRAIL)및 그 수용체들의 mRNA 발현
Expression of Transforming Growth Factor beta - 1 in Chronic Hepatitis and Hepatocellular Carcinoma Associated with Hepatitis C Virus Infection
Clinical usefulness of serum isocitrate dehydrohnase as a marker of centrilobular hepatic necrosis in patients with hyperthyroidism
Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis.
Effects of cytochrome P450 2E1 polymorphism on hepatic injury in patients with alcoholic liver cirrhosis
Experimental model of hepatic fibrosis following repeated periportal necrosis induced by allylalcohol.
Expression of Transforming Growth Factor Alpha mRNA in Livers of Patients with Chronic Viral Hepatitis and Hepatocellular Carcinoma
Expression of transforming growth factor-alpha mRNA in livers of patients with chronic viral hepatitis and hepatocellular carcinoma.
Fibrosing cholestatic hepatitis: a report of three cases
Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea.
Increasing Plasma Insulin-Like Growth Factor II Levels are Associated with Metastasis of Hepatocellular Carcinoma Following Transcatheter Arterial Chemoembolization
Lamivudine Rescue from the Accelerating Course of Chronic Hepatitis B
Lamivudine therapy for chronic hepatitis B : efficacy, predictive factors for response and relapse rate after treatment
Radioresponse of Hepatocelluar Carcinoma - Treatment of Lymph Node Metastasis -
Albumin mRNA in Peripheral Bloods as a Marker of Extrahepatic Metastasis in Patients with Hepatocellular Carcinoma
Comparison of Clinical Feat uresand Response to Ursodeoxycholic Acid Therapy in Autoimmune Cholangitis and Primary Biliary Cirrhosis
Effect and Safety of 12 Week Lamivudine Therapy in Patients with Chronic Hepatitis B
Hepatitis B Viral Markers of Korean Adults in the Late 1990s : Survey Data of 70,347 Health Screenees
Hepatocellular carcinoma not related to hepatitis B virus infection among Alaska natives.
Percutaneous hot saline injection therapy: effectiveness in large hepatocellular carcinoma.
Adult-to-Adult Living Donor Liver Transplantation
Correlation of p53 Mutations and Microvascular Invasions of Hepatocellular Carcinoma: A Possible Factor of Poor Prognosis Following Surgical Resection
Efficacy of Combination of Interferon α2a, Ribavirin and UDCA in the Treatment of Chronic Hepatitis C
Experimental Model of Hepatic Fibrosis Following Repeated Periportal Necrosis Induced by Allylalcohol
Expression of Transforming Growth Factor-β1 mRNA in Hepatocelluar Carcinoma and Surrounding Liver
Hepatitis C virus genotyping of 100 consecutive anti-HCV positive cases with PCR using type-specific primers
Ischemic Bile Duct Injury as A Serious Complication Following Transarterial Chemoembolization
Proton Magnetic Resonance Spectroscopic Findings in Cirrhotic Patients with Hepatic Encephalopathy : The Significance of Decreased Myoinositol / Creatine Ratio
Recurrences of Hepatocellular Carcinoma Following Initial Remission by Transarterial Chemoembolization
Transiugular Liver Biopsy: The Adequacy and Safety
Clinical Significance of Lens Culinaris Agglutinin-A Reactive Alpha-fetoprotein(L3) for the Diagnosis of Hepatocellular Carcinoma
간 이식후 primary dysfunction of graft에 대한 prostaglandin의 치료 효과
Two Cases of Esophagogastric Variceal Bleeding Caused by Portal Vein Thrombosis as a Sequelae of Omphalitis
A Case of Mucinous Ductal Ectasia of the Pancreas
Three-Headed 99mTc-RBC SPECT를 이용한 간혈관종의 진단
흰쥐에서 간소엽중심부 괴사와 문맥주위부 괴사와의 감별을 위한 혈청 Isocitrate Dehydrogenase 활성도의 측정
HBsAG 음성 만성 간질환 환자에서 중합효소 연쇄반응법을 이용한 혈청내 B형 간염 바이러스 DNA 및 C형 간염 바이러스 RNA의 검출
간세포암에 대한 화학색전요법에 있어서 Cisplatin과 Adriamycin의 효과
간경변증 환자에서 발생한 특발성 세균성 농흉
99mTc-RBC SPECT를 이용한 간혈관종의 진단
경구 Nitrate 제재투여로 호전된 Biliary dyskinesia 1예
체외충격파쇄석술을 이용한 담낭결석의 치료
노출혈관을 동반한 소화성 궤양 출혈환자에 대한 레이저 지혈요법
체외충격파 쇄석술 및 내시경적 유두 괄약근 절개술로 제건된 총담관 거대 담석 2예
상부 위장관 내시경 검사시 동맥혈 산소 포화도의 변화에 관한 연구
만성 간질환 환자에서 혈청 Alpha-Fetoprotein 치의 비특이적 상승을 유발하는 요인에 관한 연구
위 정맥류 대량출혈을 동반한 골수섬유증의 치험 1예
대량의 하부장관 출혈을 유발한 혈관 이형성증 1예.
저서
인터벤션영상의학
암에 대한 모든 것 (가림건강신서 54)
동병원 동일과 LIST
궤양성대장염,염증성장질환,크론병,임상연구클리닉
조기위암,조기식도암,내시경치료,위궤양,십이지장궤양
조기대장암,조기유암종,내시경치료,대장암,소장질환
궤양성대장염,크론병,베체트장염,장결핵,염증성장질환
타병원 동일과 LIST
비에비스나무병원
소화불량,위염,위암,역류성식도염,과민성대장증후군
순천향대학교 부천병원
췌장질환,담도질환,담낭질환,소화기질환
서울대학교병원
만성간염,간섬유화,간경변,간세포암종,급성간부전
부산대학교병원
위암,식도암,상부위장관질환,위장관운동질환
순천향대학교 서울병원
췌담도치료내시경,담석증,췌장염,췌담도암,담도암
서울대학교병원
위장질환,대장질환,위암,대장암,식도암
강남세브란스병원
간염,항바이러스치료,지방간,알코올성간질환
분당서울대학교병원
급성간질환,만성간질환,간경변,간암
강북삼성병원
염증성장질환,대장암,소장질환,대장질환
강남세브란스병원
식도암,위선종,위암,대장암,위식도역류질환
신촌세브란스병원
식도암,위암,내시경치료술,역류,소화관운동질환
한양대학교병원
역류성식도염,기능성소화불량증,과민성장증후군
가톨릭대학교 성빈센트병원
염증성장질환,치료내시경,위장질환,대장질환
분당서울대학교병원
위암,위염,위궤양,장염,대장암
충남대학교병원
식도암,위암,대장암,역류성식도염,위궤양
신촌세브란스병원
췌장암,담도암,신경내분비종양,항암약물치료
순천향대학교 서울병원
식도종양,위장관종양,위장관기능장애,운동질환
고려대학교 안암병원
위장관양성질환,식도암,위암,대장암
고려대학교 안암병원
위장관질환,위암,대장암,염증성장질환
고려대학교 안암병원
간암,간질환,간염,간경변증,간경화
가톨릭대학교 서울성모병원
간염,간암,간이식,지방성간질환,난치성간질환
신촌세브란스병원
췌장암,담도암,신경내분비종양,항암치료,치료내시경
신촌세브란스병원
염증성장질환,대장암,소화기질환
부산대학교병원
위장관질환,대장질환,염증성장질환,베체트병,장결핵
고신대학교복음병원
췌장질환,담도계질환,담석증,담낭염,담관염,췌장암
삼성서울병원
역류성식도염,변비,기능성소화불량,아칼라지아
삼성서울병원
담낭용종,담도암,담낭암,담도폐쇄,췌장질환
삼성서울병원
담낭용종,담도암,담도폐쇄,담석증,췌장의질환
삼성서울병원
간암,간경화,급성간염,만성간염,간질환
가톨릭대학교 서울성모병원
위암,위식도역류질환,식도암
삼성서울병원
위염,십이지장궤양,위궤양,위장질환,기능성소화불량
삼성서울병원
간암,간경화,급성간염,만성간염,지방간,간질환
삼성서울병원
위암,위식도역류질환,소화성궤양,기능성소화불량
삼성서울병원
간암,간경화,급성간염,만성간염,지방간,간질환
삼성서울병원
췌장암,담낭암,담도암,췌장염,췌장의양성종양 담석증
삼성서울병원
간암,간경화,급성간염,만성간염,지방간,간질환
삼성서울병원
암,치료내시경,위선종,식도암,위의양성종양,소화불량
삼성서울병원
염증성장질환,궤양성대장염,크론병,조기대장암
삼성서울병원
염증성장질환,장결핵,대장암,크론병,궤양성대장염
삼성서울병원
대장암,대장용종,혈변,유전성대장암,염증성장질환
삼성서울병원
위암,위선종,위의양성종양,치료내시경,위장질환
삼성서울병원
췌장암,담낭암,담도암,췌장염,췌장의양성종양
삼성서울병원
대장암,대장용종,소장질환,염증성장질환,대장협착
삼성서울병원
기능성 식도질환및식도암,기능성소화불량,위암
삼성서울병원
간암,간경화,급성간염,만성간염,지방간,간이식
삼성서울병원
치료내시경,초음파내시경,위암,장질환
가톨릭대학교 서울성모병원
간이식,간암,간염,담도암
가톨릭대학교 서울성모병원
담관질환,담도암,췌장질환,치료내시경
가톨릭대학교 서울성모병원
대장암용종,크론병,장베체트병,궤양성대장염
가톨릭대학교 서울성모병원
소화기종양치료내시경,위암
가톨릭대학교 서울성모병원
위암,위염,소화성궤양,내시경초음파
가톨릭대학교 서울성모병원
간염,간암,간경변,간이식
삼성서울병원
심장혈관중재시술,협심증,심근경색증
이대목동병원
위암,헬리코박터감염,위식도역류질환
고려대학교 안암병원
췌담도질환,담석,담낭염,담도암,췌장염
고려대학교 안암병원
췌담도질환,담석,담낭염,담도암,췌장염
강남세브란스병원
췌장담도질환,췌담도암,췌담도양성질환
강남세브란스병원
치료내시경,위암,식도암,대장암,위식도역류질환
강동경희대학교병원
대장내시경,대장암,대장용종,위암,식도암
용인세브란스병원
소화기암,치료내시경,췌장담도계질환
동국대학교 일산병원
간질환,지방간,간염,간경변,간암,소화기일반
동국대학교 일산병원
소화기질환, 소화기암,위장관운동질환,염증성장질환
순천향대학교 부천병원
위,식도간질환,대장항문병
순천향대학교 부천병원
위,식도대장항문병,소화기
순천향대학교 부천병원
식도위질환치료내시경,기능성위장질환
보라매서울대학교병원
역류성식도염,위염,위궤양,대장질환소화기암
보라매서울대학교병원
식도염,위염,위궤양,소화불량,소화기암
보라매서울대학교병원
급성만성간질환,간경변,간암,위염,위궤양
인제대학교 서울백병원
위염,위암,소화불량,식도염
|
|